Tag Archives: Medicaid

Gem of the Week: Big Pharma in Juvie

This week’s gem for reporting on science, health, and the environment goes to… the Palm Beach Post in Florida, for revealing ties between psychiatrists in juvenile halls and manufacturers of antipsychotic drugs. The Post’s investigation found that a handful of psychiatrists working for Florida’s Department of Juvenile Justice (DJJ) were paid high speaking fees or given gifts by pharmaceutical companies like AstraZeneca. “In at least one case, the number of Medicaid prescriptions a psychiatrist wrote for children rose sharply around the time he was paid, The Post found.” Even worse, the antipsychotics were prescribed by the DJJ doctors were not approved for safe use in children.

Brooklyn’s Kingsboro Psychiatric Center a ‘violent’ madhouse with deaths linked to paperwork snafus

A Brooklyn mental hospital is a violence-wracked, dangerous place, rife with assaults and at least two deaths linked to paperwork snafus, the Daily News has learned. Federal surveys and court documents paint a disturbing portrait at the state’s problem-plagued Kingsboro Psychiatric Center. “Violence has become a way of life at KPC,” an independent mental health expert wrote in a Kingsboro-commissioned 2009 report after the hospital was sued in federal court.

Court Ruling Clears Way for Jury Trial in $1 Billion Texas Medicaid Whistleblower Lawsuit

A recent state district court ruling has cleared the way for a jury to hear claims filed by the State of Texas and plaintiff Allen Jones based on allegations that pharmaceutical manufacturer Janssen L.P. used false marketing tactics to convince state officials to spend millions on a schizophrenia drug…The drug was no better and no safer despite being substantially more expensive than older medications that treat the same illness, the lawsuit alleges. Janssen worked to build revenue by actively and purposefully marketing the powerful antipsychotic drug for use in children, the lawsuit says, even though the medication was approved only for the very narrow purpose of treating adult schizophrenia.

Concern over high medication rate among foster kids—Review of kids’ psych drugs urged

Giovan Bazan was 6 when a doctor first gave him medicine to treat his diagnosis of hyperactivity. Bazan admits he was unruly at the time. Perhaps it was because the only parent he had ever known, his foster mother since he was an infant, had just died. No one asked about that. Nor did anyone check years later to see that he was on a double dose of Ritalin when another physician, seeing a boy so mellowed out that he barely reacted, prescribed an antidepressant. “They start you on one thing for a problem, then the side effects mean you need a new medicine,” Bazan said. “As a foster kid, I’d go between all these doctors, caseworkers, therapists, and [it] seemed like every time there was a new drug to try me on.”

When he turned 18, Bazan elected to stop all medications. It turned out he didn’t need any of them.